Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Markus Kapp"'
Autor:
Alexander Kiani, Romina Roesch, Clemens M. Wendtner, Frank Kullmann, Thomas Kubin, Thomas Südhoff, Marinela Augustin, Markus Schaich, Clemens Müller‐Naendrup, Gerald Illerhaus, Frank Hartmann, Holger Hebart, Ruth Seggewiss‐Bernhardt, Martin Bentz, Ernst Späth‐Schwalbe, Peter Reimer, Ulrich Kaiser, Markus Kapp, Ullrich Graeven, Jens‐Marcus Chemnitz, Jörg Baesecke, Helmut Lambertz, Ralph Naumann
Publikováno v:
Cancer Medicine, Vol 10, Iss 13, Pp 4424-4436 (2021)
Abstract Background Infection with SARS‐CoV‐2 leads to COVID‐19, the course of which is highly variable and depends on numerous patient‐specific risk factors. Patients with tumor diseases are considered to be more susceptible to severe COVID
Externí odkaz:
https://doaj.org/article/189b72c7a94844858de97e82ef190873
Publikováno v:
Case Reports in Oncology, Vol 9, Iss 1, Pp 15-24 (2016)
Ampullary carcinoma is a rare tumor and evidence on the treatment of recurrent metastatic disease is scarce. We report the case of a 60-year-old patient with an R0-resected node-positive adenocarcinoma of the papilla of Vater of an initially diagnose
Externí odkaz:
https://doaj.org/article/407d69c3006e4ab79fdb97c873de7453
Publikováno v:
Case Reports in Oncology, Vol 7, Iss 3, Pp 648-655 (2014)
The prognosis of patients with locally advanced pancreatic cancer can be improved if secondary complete (R0) resection is possible. In patients initially staged as unresectable this may be achieved with neoadjuvant treatment which is usually chemorad
Externí odkaz:
https://doaj.org/article/6259161704de4c2d834dca5721ef6a71
SMAC mimetic BV6 induces cell death in monocytes and maturation of monocyte-derived dendritic cells.
Autor:
Nicole Müller-Sienerth, Lena Dietz, Philipp Holtz, Markus Kapp, Götz Ulrich Grigoleit, Carsten Schmuck, Harald Wajant, Daniela Siegmund
Publikováno v:
PLoS ONE, Vol 6, Iss 6, p e21556 (2011)
BACKGROUND: Compounds mimicking the inhibitory effect of SMAC/DIABLO on X-linked inhibitor of apoptosis (XIAP) have been developed with the aim to achieve sensitization for apoptosis of tumor cells resistant due to deregulated XIAP expression. It tur
Externí odkaz:
https://doaj.org/article/992b156064774803810a9e3ff7bbce9b
Autor:
Markus Kapp, Peter Reimer, Thomas Kubin, Ralph Naumann, Clemens Müller-Naendrup, Ernst Späth‐Schwalbe, Frank Kullmann, Romina Roesch, Helmut Lambertz, Martin Bentz, Alexander Kiani, Markus Schaich, Holger Hebart, Frank Hartmann, Ulrich Kaiser, Ruth Seggewiss-Bernhardt, Jens‐Marcus Chemnitz, Gerald Illerhaus, Clemens M. Wendtner, Thomas Südhoff, Jörg Baesecke, Ullrich Graeven, Marinela Augustin
Publikováno v:
Cancer Medicine, Vol 10, Iss 13, Pp 4424-4436 (2021)
Cancer Medicine
Cancer Medicine
Background Infection with SARS‐CoV‐2 leads to COVID‐19, the course of which is highly variable and depends on numerous patient‐specific risk factors. Patients with tumor diseases are considered to be more susceptible to severe COVID‐19; how
Autor:
Christoph Seidl, Arndt Hartmann, Rumo Leistner, Christoph Schubart, Wolfgang Hohenforst-Schmidt, Gerhard Seitz, Michael Vieth, Horia Sirbu, Lars Tögel, Florian S. Fuchs, William Sterlacci, Ruth Seggewiss-Bernhardt, Robert Stöhr, Markus Kapp, Ramona Erber, Michael Mugler, Florian Haller
Publikováno v:
Cancers
Volume 13
Issue 19
Cancers, Vol 13, Iss 5023, p 5023 (2021)
Volume 13
Issue 19
Cancers, Vol 13, Iss 5023, p 5023 (2021)
In non-small cell lung cancer (NSCLC), approximately 1–3% of cases harbor an increased gene copy number (GCN) of the MET gene. This alteration can be due to de novo amplification of the MET gene or can represent a secondary resistance mechanism in
Publikováno v:
Current Opinion in Infectious Diseases. 30:372-376
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) has become one of the standard treatment for hematological diseases. Although the clinical outcome has improved significantly during the last decades, the morbidity and mortality after al
Publikováno v:
Bone Marrow Transplantation. 52:657-662
Diabetes mellitus (DM) is well-known as a disorder that increases the risk of infectious diseases. Various reports have shown that innate immunity is impaired in patients with DM, which is considered to be a major cause of increased risk of infectiou
Autor:
Anne Deuretzbacher, Elke Baumeister, Andreas Beilhack, Markus Kapp, Harald Wajant, Carolin Köchel, Nergui Dagvadorj, Daniela Weisenberger, Isabell Lang, Johannes Trebing, Kerstin Kapp, Thomas Hünig, Hermann Einsele, Götz Ulrich Grigoleit
Publikováno v:
Cancer Immunology, Immunotherapy. 66:319-332
Due to its immunogenicity and overexpression concomitant with leukemia progression, Wilms tumor protein 1 (WT1) is of particular interest for immunotherapy of AML relapse after allogeneic hematopoietic stem cell transplantation (allo-HSCT). So far, W
Publikováno v:
Virulence. 7:939-949
The outcome after allogeneic haematopoietic stem cell transplantation (allo-HSCT) has significantly improved during the last decades. However, opportunistic infections such as viral and mold infections are still a major obstacle for cure. Within this